2,4,5-trichlorophenoxyacetic acid has been researched along with salmeterol xinafoate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Snodin, DJ | 1 |
1 other study(ies) available for 2,4,5-trichlorophenoxyacetic acid and salmeterol xinafoate
Article | Year |
---|---|
Regulatory immunotoxicology: does the published evidence support mandatory nonclinical immune function screening in drug development?
Topics: 2,4,5-Trichlorophenoxyacetic Acid; Adrenergic beta-Agonists; Albuterol; Allergy and Immunology; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; European Union; Guidelines as Topic; Herbicides; Humans; Immunity; Narcotics; Rats; Salmeterol Xinafoate; Toxicology; United States; United States Food and Drug Administration | 2004 |